weaning off glp 1 Tapering glp-1s, How to do it both effectively and safely Weaning Off GLP-1 Medications: Safe
Description
Gut and systemic GLP-1 resistance have been previously described in HFD-fed mice, associated with dysglycemia, insulin resistance, increased food intake, and impaired gastric emptying, and attributed to an acquired impairment of the gut-brain axis secondary to intestinal dysbiosis (34)

REFERENCES The increase in appetite for obesity drugs

Co., Ltd Company Overview Financial Insights Product/ Services Offerings Strategic Developments SWOT Analysis Roche Company Overview Financial Insights Product/ Services Offerings Strategic Developments SWOT Analysis Zealand Pharma Company Overview Financial Insights Product/ Services Offerings Strategic Developments SWOT Analysis Biocon Limited Company Overview Financial Insights Product/ Services Offerings Strategic Developments SWOT Analysis

Medication selection and dose titration are individualized, with clear follow-up schedules and access to clinicians via messaging to report side effects or concerns
